Investigation of the effect of Ketamine in comparison with Dexmedetomidine dose in pain management and postoperative complications of orthopedics

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161014030294N5

Enrollment

Registered

2021-01-13

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral orthopedic surgery. femoral fracture

Interventions

Intervention 1: Intervention group: They receive ketamine at a dose of 1 mg / kg in the pain pump after the operation. Complications and pain scores are observed before the intervention and after 8 ho

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 to 65 years orthopedic surgery of the lower limb or pelvis with general anesthesia consent to research absence of underlying diseases such as cardiovascular physical condition 1 and 2 American Society of Anesthesiologists (ASA)

Exclusion criteria

Exclusion criteria: Hypersensitivity to Ketamine or Dexmedetomidine cardiovascular and pulmonary disease death of patient dissatisfaction with participation in the study withdrawal from the study at any stage

Design outcomes

Primary

Measure	Time frame
The extent of postoperative pain. Timepoint: Pain score before the intervention and after up to 8 hours after the operation every hour. Method of measurement: VAS scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansoreh Karimi Kia

Arak University of Medical Sciences

karimikia93@gmail.com+98 86 3313 6055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026